Details for New Drug Application (NDA): 214890
✉ Email this page to a colleague
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 214890
Tradename: | DEXAMETHASONE SODIUM PHOSPHATE |
Applicant: | Geneyork Pharms |
Ingredient: | dexamethasone sodium phosphate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG PHOSPHATE/ML | ||||
Approval Date: | Jul 7, 2023 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4MG PHOSPHATE/ML | ||||
Approval Date: | Jul 28, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription